Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm not a chart reader but when I look at the 10,50, and 200, combined with the trends I saw going on in their earnings, I believe we will be moving up. I think many are thinking Biden is going to make a move on medical cannabis over the next year, and many of these companies are starting to prove themselves.
I'm not worried. Our last earnings showed many good things going on. I'm in acb, tilray, ogi, hiti, and ayrwf. I believe in all of them.
No problem, the opportunities to stay solvent are available to OGI ( time,pps increase etc.) the threat of delisting should be seen as just a shot across the bow warning.
Exactly, "The Notification has no immediate effect on the listing of the Company’s common shares on the NASDAQ Global Select Market."
To post to others what you are talking about.. it's not a big deal yet, but could be as we don't want ogi to be forced into a rs.
The Notification has no immediate effect on the listing of the Company’s common shares on the NASDAQ Global Select Market. Under NASDAQ Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from the date of Notification, being until July 24, 2023, to regain compliance with the Minimum Bid Requirement, during which time the common shares will continue to trade on the NASDAQ Global Select Market. If at any time before July 24, 2023, the bid price of the common shares closes at or above US$1.00 per share for a minimum of 10 consecutive business days, the Company will regain compliance with the Minimum Bid Requirement. In the event the Company does not regain compliance with the Minimum Bid Requirement by July 24, 2023, the Company may be eligible for an additional period of 180 calendar days to regain compliance or may be subject to delisting of the common shares from the NASDAQ Global Select Market. The Company’s common shares are also listed on the Toronto Stock Exchange and the Notification does not affect the Company’s compliance status with such listing.
omit the word "no" should read Is not awesome.
Awesome ? today's possible Delisting is not no awesome.
OrganiGram's a solid company. Here's the company's "Investor Presentation" for you.
https://investors.organigram.ca/sites/default/files/documents/Organigram_Q4%20Investor_Presentation.pdf
Congratulations on grabbing some cheap shares Mike!
Higher today on nice volume. I added 5000 shares and hope it is not a "pump and dump" by the big boys. Good luck all.
OGI has become an awesome company. Awesome financials!
Thanks, WeedIsGreen, great news! Patience always pays here at OGI at least it has for me.
Earnings out! "“In Q1 Fiscal 2023, we achieved the highest adjusted gross margin in the Company's history at $13 million, continued the trend of positive Adjusted EBITDA and delivered positive net income and cash flow,” added Derrick West, Chief Financial Officer. “With the expected completion of the expansion at our Lac-Supérieur facility and continuous improvements in automation and cultivation, we have built a long-term platform to serve increasing market demands and generate value.”"
Love the potential!
I feel optimistic about OrganiGrams exports, see below......
• In Fiscal 2022, shipped $15.4 million of dry flowers internationally
• Supply of dried flowers to Canndoc for processing and distribution into Israeli medical market1
• Opportunity to launch Organigram-branded medical products in Israel, and grants exclusivity
and related rights to Canndoc in the Israel market
• November 2022: entered into a new multi-year Strategic Agreement with Canndoc to supply up
to 20,000kg of dry flowers to Israel
• Multiple shipments made to Cannatrek Medical in Australia- one of Australia's leading medical
cannabis companies
• In FY22, commenced shipments to MEDCAN in Australia
SOURCE: https://investors.organigram.ca/sites/default/files/documents/Organigram_Q4%20Investor_Presentation.pdf
Guess we'll see. Good luck WeedIsGreen.
OGI
.
Yeah. I lucked out the first time around when it reached its highest PPS of $7.85. I sold 2/3s of my holdings, very close to that price, and made out well. I reinvested when it dropped significantly, but since then, I'm in the hole, but all I need is an eventual run to $1.27 USD, and I'm back on profits. I want to believe it will make another run again, and if it gets back to that minimum, my big decision will be how long I'm willing to hold on until I dump this stock for good. If it runs up a few dollars, I stand to do well again, and it will serve its purpose...but I'm good with breaking even and moving on. It's sad this has turned into a penny stock!
Earnings tomorrow! Tilray's wasn't anything wonderful which brought everyone down . Hopefully we have one that shows a good trend like the last one!
OGI Hi WeedIsGreen! OrganiGram News Releases. https://investors.organigram.ca/press-releases You can also sign up for their newsletter. I will try to post news because we have a few investors whose countries block anything regarding Canibus.
OGI does this, and goes low along with all the other Canibus tickers. It always bounces nicely though. Spring is still usually a seasonal high for the pps (price per share). We'll see how it does.
Yeah, I went all in on cannabis and feel I'm in with the companies that will make it through this out of flavor stockmarket where overall has a large short. If I could have predicted the future I would have waited obviously.... but I had cold feet when other markets came online and lost out(as far back as AOL is one of many examples) Told myself not this time as we all know cannabis has a medical purpose, meaning it's scheduled wrong in the USA. Other countries will follow once medically allowed at the fed level. Once it medically legal in the USA,, new investors, like the retirement funds can invest in this market. After medically legal, and maybe in 2024 or after Biden, I'm better rec will be legal or at least the discussions which will create another frenzy
Sweet. I watched the ceo's interview on bnn regarding the last earnings that was reported a while back. She seems pretty good. Isreal was a large parts in the sales. If it's like what happened with acb, those sales don't happen every quarter shipping to Isreal. I'm a newer investor here, so they might have enough diversity to continue the trend having nice growth quarter over quarter... which will be huge imo! Hopefully inflation isn't causing a lot of issues. She said that the excise tax was Canadian put in place was when the price per gram was $10, but it's selling it under $4. Did you catch anything lately about reducing that tax?
Thanks HunchBackGeek
OGI STRONG BALANCE & SHEET AND LIQUIDITY......
• Capital position is healthy, and there is sufficient liquidity
available for the near to medium term
• On August 31, 2022, the Company had cash and short-term
investments (excluding restricted funds) of $98.6 million
• Negligible debt (less than $0.3 million)
https://investors.organigram.ca/sites/default/files/documents/Organigram_Q4%20Investor_Presentation.pdf
.
Thanks. I need 2.5 dollars US to break even and would love a small profit on top of that. I made the investment one year ago November so if I make money at least it will be a long term capital gain. Maybe we will both make out. Good luck.
I agree with you, mike1986. I've been with OGI for years, and it's frustrating. It also gets old hearing the same ole rah-rah speech from the fanboys when this stock continues to stay in a downward spiral. Fortunately, I'm playing with house money and sold a bunch when it was nearly at its all-time high. I'm just hoping for one last little run now to break even and then I'm dumping it. I've given them their chance to show sustainable and upward PPS over a few years now, but if anything, it has been the opposite for quite some time now. Good luck.
I agree. I just want to see that reflected in the share price for a change.
OGI Great company with solid management.
Hopefully if their is positive news the stock market will finally give this company its due. So far they have trashed it, I believe very unfairly.
January/5th/2023
Organigram to Report First Quarter Fiscal 2023 Results on January 12, 2023
Toronto, Ontario – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2023 ended November 30, 2022, on Thursday, January 12, 2023, before market open.
The Company will host a conference call to discuss its results with details as follows:
Date: Thursday, January 12, 2023
Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
https://conferencingportals.com/event/RUyBPhzX
To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.
To access the webcast:
https://events.q4inc.com/attendee/655133665
Participants will receive their details via email.
A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews in Canada.
Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For media inquiries:
Paolo De Luca
Chief Strategy Officer
paolo.deluca@organigram.ca
For investor inquiries:
investors@organigram.ca
Source: Organigram Holdings Inc.
https://investors.organigram.ca/press-releases/organigram-to-report-first-quarter-fiscal-2023-results-on-january-12-2023
.
iT WILL TAKE MUCH MORE THEN THAT TO DO SO !!!!!SHOW ME THE MONEY !!!!1
Yeah it seems OGI has had a string of positive news that has not affected PPS. Hopefully this is a case of the baby being throw out with the bathwater as the entire MJ industry has been soft.
Nice article but it hasn't moved the PPS needle.
Organigram wins Cannabis Company of the Year Award......
Organigram wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS (December 8th, 2022)
Toronto, Ontario – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is pleased to announce it has won KIND Magazine’s (“KIND”) Cannabis Company of the Year award. Considered KIND’s marquee award, Cannabis Company of the Year is presented to the licensed producer that the KIND editorial team believes demonstrates the best combination of people, purpose and product in a given year.
“We are very proud to be recognized by KIND Magazine,” says Beena Goldenberg, CEO, Organigram. “The Cannabis Company of the Year award is particularly special because it not only acknowledges Organigram as a top performing licensed producer, but also celebrates the high-quality of our talented employees from coast-to-coast. Likewise, the award is unique as it considers ‘purpose’, recognizing Organigram’s commitment to doing good in the communities we serve.”
In addition to the Cannabis Company of the Year award, the Company’s Edison Cannabis Co. brand’s Edison JOLTS, Canada’s first high-potency lozenge, received the Most Innovative Product of the Year. This award is voted on by budtenders and retail owners from across Canada.
“We are excited to receive these accolades from some of the most influential voices in the industry, including both the KIND editorial team and our industry’s retailers and budtenders,” says Eric Williams, Senior Director of Marketing, Organigram. “We share KIND’s commitment to making cannabis a part of Canadian culture and are proud to be recognized by the hard-working retailers and talented budtenders who bring their expertise and passion to support Canadians’ experience of our products every day.”
Organigram was nominated in two other categories including Hash of the Year for the Company’s Tremblant Hash and CBD Brand of the Year for its wellness brand, Monjour.
“It felt great to select Organigram for our KIND Cannabis Company of the Year because they do everything with love — you just know it's a company that cares for our community,” says Joshua Nagel, Founder & Chief Dream Officer at KIND. “They had an impressive year, both from a financial and market share growth perspective, and have also built beloved consumer brands including Edison, SHRED and Big Bag o’ Buds, but that's just the half of it. They're also great human beings to work with and we were impressed with their commitment to helping their local communities: Organigram is the kind of company that makes all of us at KIND happy to be working in weed.”
For more information about Organigram or its brands, please visit organigram.ca
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Holy Mountain, Wo La, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions and consumer preferences, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For Investor Relations enquiries:
investors@organigram.ca
For Media enquiries:
Paolo De Luca
paolo.deluca@organigram.ca
Chief Strategy Officer, Organigram
SOURCE: https://investors.organigram.ca/press-releases/organigram-wins-kind-magazines-cannabis-company-of-the-year-award-and-most
.
Agreed, time to load! OGI Yes, indeed.
Multi year lows are usually great loading zones
Shorty has down to 6 Year low .Time to load
OGI ~ OrganiGrow Organigram has developed its own in-house proprietary information technology system called OrganiGrow, a database that tracks all grow cycles by harvest period, strain, room, environmental conditions, and other factors, which in turn allows the Company to understand and refine the optimal methods to grow cannabis plants. It is the Company’s intention to continually improve and refine its cultivation and post-harvesting practices in an effort to achieve a competitive advantage in the space.
It's all about the timing.
I'm pumped as they will get caught hard when things get rescheduled in the US
That's nothing. This, hiti, and acb are undervalued at these prices I'm jaw dropped
I would love to know who the short sellers are manipulating this stock downward. There is no good reason for this.
OGI Excellent! Welcome, WeedIsGreen
OGI Thanks John1311! Great to see you bud
I'm now an investor here too! Nice to see this sector starting to ger a little love again. To me, hiti and ogi are both beat up and undervalued.
Cannabis stocks extended recent gains to stage a rally towards the market close on Friday after President Joe Biden signed a marijuana research bill into law.
Notable gainers include Clever Leaves (CLVR), SNDL Inc. (SNDL), MedMen Enterprises (OTCQB:MMNFF), Canopy Growth Corporation (CGC), Tilray Brands (NASDAQ:TLRY), TerrAscend Corp. (OTCQX:TCNNF), OrganiGram Holdings (OGI), Aurora Cannabis (ACB), GrowGeneration (GRWG) and Cronos Group (CRON)
The bill named Medical Marijuana and Cannabidiol Research Expansion Act cleared the House in April and the Senate last month.
It establishes a new registration process for cannabis-related research and the production of marijuana for research and drug development.
https://seekingalpha.com/news/3913664-tlry-stock-sndl-stock-lead-cannabis-stocks-higher-as-biden-signs-marijuana-law?mailingid=29873306&messageid=2900&serial=29873306.8691&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha&utm_term=29873306.8691
ogi USUALLY RUNS ANNUALLY AND IS RUNNING LATE ON IT'S RUN THIS YEAR
OGI is due for a little run
Followers
|
180
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
11308
|
Created
|
08/27/14
|
Type
|
Free
|
Moderators WALL STREET KID Hunchbackgeek |
Efficient Vertical Growth Infrastructure! | 137 000 sq ft. Expansion Under Construction! | Recreational Edibles Coming! |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |